Annotation Detail

Information
Associated Genes
CYP2C9
Associated Variants
CYP2C9 MUTATION
CYP2C9 MUTATION
CYP2C9 p.Arg144Cys (p.R144C) ( ENST00000461906.1, ENST00000260682.8 )
EPHX1 p.Tyr113His (p.Y113H) ( ENST00000614058.4, ENST00000272167.10, ENST00000366837.5 )
EPHX1 p.His139Arg (p.H139R) ( ENST00000272167.10, ENST00000366837.5, ENST00000614058.4 )
EPHX1 p.His139Leu (p.H139L) ( ENST00000614058.4, ENST00000366837.5, ENST00000272167.10 )
CYP2C9 p.Arg144Cys (p.R144C) ( ENST00000260682.8, ENST00000461906.1 )
EPHX1 p.Tyr113His (p.Y113H) ( ENST00000272167.10, ENST00000366837.5, ENST00000614058.4 )
EPHX1 p.His139Arg (p.H139R) ( ENST00000272167.10, ENST00000366837.5, ENST00000614058.4 )
EPHX1 p.His139Leu (p.H139L) ( ENST00000272167.10, ENST00000366837.5, ENST00000614058.4 )
Associated Disease
Craniofacial Abnormalities
Source Database
DisGeNET
Description
The goal of this study was to assess the effect of maternal genotype of functional polymorphisms in two genes involved in phenytoin metabolism, CYP2C9 (R144C, I395L) and EPHX1 (Y113H, H139R), on the presence of major craniofacial abnormalities (CFAs) in the child.
Pubmed
19952982
Original source reporting the Gene Disease association
BeFree
DisGENET score for the Gene Disease association
0.000271441872080303
Year of publication
2010
Drugs